Mainz Biomed (MYNZ) Short Interest Ratio & Short Volume → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free MYNZ Stock Alerts $0.66 -0.06 (-8.34%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Mainz Biomed Short Interest DataCurrent Short Volume301,500 sharesPrevious Short Volume307,300 sharesChange Vs. Previous Month-1.89%Dollar Volume Sold Short$295,470.00Short Interest Ratio / Days to Cover3.6Last Record DateApril 15, 2024Float Size13,120,000 sharesShort Percent of Float2.30%Today's Trading Volume171,439 sharesAverage Trading Volume105,735 sharesToday's Volume Vs. Average162% Short Selling Mainz Biomed ? Sign up to receive the latest short interest report for Mainz Biomed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMYNZ Short Interest Over TimeMYNZ Days to Cover Over TimeMYNZ Percentage of Float Shorted Over Time Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. Mainz Biomed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024301,500 shares $295,470.00 -1.9%2.3%3.6 $0.98 3/31/2024307,300 shares $316,519.00 -3.1%2.3%3.5 $1.03 3/15/2024317,100 shares $329,784.00 -8.7%2.8%3.5 $1.04 2/29/2024347,200 shares $306,959.52 -17.6%3.0%2.8 $0.88 2/15/2024421,500 shares $421,500.00 -16.1%3.7%2.1 $1.00 1/31/2024502,100 shares $487,037.00 -14.9%4.4%2 $0.97 Get the Latest News and Ratings for MYNZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mainz Biomed and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024589,900 shares $704,930.50 +8.0%5.2%2.5 $1.20 12/31/2023546,100 shares $633,476.00 +68.6%4.8%2.4 $1.16 12/15/2023324,000 shares $336,960.00 +112.6%2.8%1.4 $1.04 11/30/2023152,400 shares $173,736.00 +10.0%1.3%0.5 $1.14 11/15/2023138,600 shares $167,706.00 +78.2%1.2%0.7 $1.21 10/31/202377,800 shares $156,378.00 -29.2%0.7%0.6 $2.01 10/15/2023109,900 shares $254,968.00 -12.1%1.0%0.9 $2.32 9/30/2023125,000 shares $365,000.00 -57.7%1.1%1 $2.92 9/15/2023295,700 shares $1.05 million +682.3%2.7%2.6 $3.54 8/31/202337,800 shares $115,668.00 +65.8%0.3%1.2 $3.06 8/15/202322,800 shares $71,820.00 +168.2%0.2%0.9 $3.15 7/31/20238,500 shares $36,210.00 -52.3%0.1%0.4 $4.26 7/15/202317,800 shares $87,220.00 +11.3%0.2%0.6 $4.90 6/30/202316,000 shares $76,480.00 -35.5%0.1%0.5 $4.78 6/15/202324,800 shares $121,520.00 -12.4%0.2%0.6 $4.90 5/31/202328,300 shares $155,367.00 -28.4%0.3%0.6 $5.49 5/15/202339,500 shares $216,855.00 +208.6%0.4%0.8 $5.49 4/30/202312,800 shares $50,816.00 -67.0%0.1%0.3 $3.97 4/15/202338,800 shares $230,472.00 -23.2%0.4%0.9 $5.94 3/31/202350,500 shares $317,140.00 +155.1%0.7%1.3 $6.28 3/15/202319,800 shares $124,344.00 -18.5%0.3%0.7 $6.28 2/28/202324,300 shares $172,287.00 +88.4%0.3%0.9 $7.09 2/15/202312,900 shares $88,365.00 +76.7%0.2%0.6 $6.85 1/31/20237,300 shares $48,180.00 -21.5%N/A0.5 $6.60 1/15/20239,300 shares $61,566.00 +304.4%N/A0.6 $6.62 12/30/20222,300 shares $16,330.00 -60.3%N/A0.1 $7.10 12/15/20225,800 shares $44,254.00 -71.1%N/A0.3 $7.63 11/30/202220,100 shares $176,277.00 +27.2%N/A1 $8.77 11/15/202215,800 shares $123,398.00 -6.0%N/A0.8 $7.81 10/31/202216,800 shares $119,280.00 -2.9%N/A0.7 $7.10 10/15/202217,300 shares $121,273.00 +1.8%N/A0.7 $7.01 9/30/202217,000 shares $117,130.00 -30.9%N/A0.6 $6.89 9/15/202224,600 shares $214,543.98 -32.2%N/A0.9 $8.72 8/31/202236,300 shares $318,714.00 -17.1%N/A1.2 $8.78Proof that the Musk/Bezos rivalry is about to hit a new level (Ad)Elon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. MYNZ Short Interest - Frequently Asked Questions What is Mainz Biomed's current short interest? Short interest is the volume of Mainz Biomed shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 301,500 shares of MYNZ short. 2.30% of Mainz Biomed's shares are currently sold short. Learn More on Mainz Biomed's current short interest. What is a good short interest ratio for Mainz Biomed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYNZ shares currently have a short interest ratio of 4.0. Learn More on Mainz Biomed's short interest ratio. What is a good short interest percentage for Mainz Biomed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.30% of Mainz Biomed's floating shares are currently sold short. Is Mainz Biomed's short interest increasing or decreasing? Mainz Biomed saw a decline in short interest in April. As of April 15th, there was short interest totaling 301,500 shares, a decline of 1.9% from the previous total of 307,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mainz Biomed's float size? Mainz Biomed currently has issued a total of 0 shares. Some of Mainz Biomed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mainz Biomed currently has a public float of 13,120,000 shares. How does Mainz Biomed's short interest compare to its competitors? 2.30% of Mainz Biomed's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Mainz Biomed: Context Therapeutics Inc. (0.29%), Grifols, S.A. (2.57%), LAVA Therapeutics (1.37%), NLS Pharmaceutics Ltd. (0.34%), Pharvaris (0.87%), Tiziana Life Sciences Ltd (0.25%), American Oncology Network, Inc. (0.83%), Centogene (0.05%), Concord Medical Services Holdings Limited (0.03%), Lucid Diagnostics Inc. (2.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Mainz Biomed stock? Short selling MYNZ is an investing strategy that aims to generate trading profit from Mainz Biomed as its price is falling. MYNZ shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mainz Biomed? A short squeeze for Mainz Biomed occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MYNZ, which in turn drives the price of the stock up even further. How often is Mainz Biomed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYNZ, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CNTX Short Squeeze GRFS Short Squeeze LVTX Short Squeeze NLSP Short Squeeze PHVS Short Squeeze TLSA Short Squeeze ATNFW Short Squeeze ACONW Short Squeeze AIMDW Short Squeeze DRTSW Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MYNZ) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings